Results 271 to 280 of about 1,553,841 (335)

Prognostic analysis and expression patterns of programmed cell death ligand 1 and BRAF V600E in esophageal neuroendocrine carcinoma. [PDF]

Oncol Lett
Zhang C, Zheng L, Xu B, Shi G, Fu M.
europepmc   +1 more source

Kidney Neuroendocrine Carcinoma [PDF]

, 2020
openaire   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Case Report: Neuroendocrine carcinoma of the breast: a review of the literature and illustration of six cases. [PDF]

Front Med (Lausanne)
Albayrak NE.
europepmc   +1 more source

Neuro‐Immune Crosstalk: Molecular Mechanisms, Biological Functions, Diseases, and Therapeutic Targets

MedComm, Volume 7, Issue 2, February 2026.
Neurons, immune cells, and other cellular components within the disease microenvironment (such as stromal cells and tumor cells) constitute a dynamically evolving ecosystem. Neurons directly modulate immune cell activity and inflammatory responses through the release of neurotransmitters (e.g., norepinephrine and CGRP), while also promoting tumor ...
Xin Guo, Hui Liu, Yu‐Jing Song, Jian‐Hua Wang, Danfeng Liu, Zhi‐Wei Zheng, Jia‐Jun Li, Boya Li, An Song, Wei He, Lei‐Lei Yang, Shuo Wang   +11 more
wiley   +1 more source

Clinicopathological characteristics and treatment of patients with colorectal neuroendocrine carcinoma: A retrospective study of 157 cases. [PDF]

Oncol Lett
Dai M, Sun S, Liu X, Li H.
europepmc   +1 more source

Molecular alterations in high‐grade neuroendocrine tumors of the small intestine

The Journal of Pathology, Volume 268, Issue 2, Page 215-226, February 2026.
Abstract High‐grade neuroendocrine tumors of the small intestine are separated into two groups: well‐differentiated neuroendocrine tumors (NETs, high‐grade) and poorly differentiated neuroendocrine carcinomas (NECs). They represent very rare entities, with few molecular data available, and are very challenging to treat.
Agathe Hercent, Julien Masliah‐Planchon, David Cohen, Remy Nicolle, Jean‐Yves Scoazec, Philippe Ruszniewski, Ivan Bièche, Louis de Mestier, Anne Couvelard, Jerome Cros   +9 more
wiley   +1 more source

Management paradigm for ovarian neuroendocrine carcinoma: a systematic review. [PDF]

J Ovarian Res
Mantilidewi KI, Winarno GNA, Harsono AB, Suardi D, Hidayat YM, Kurniadi A, Salima S, Erfiandi F, Haniah AS, Kampan NC.   +9 more
europepmc   +1 more source

High Burden of Pancreatic Surgery for Intraductal Papillary Mucinous Neoplasia With Low‐Grade Dysplasia and Benign Cysts: A Systematic Review and Meta‐Analysis

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Intraductal papillary mucinous neoplasms with low‐grade dysplasia (IPMNs w/LGD) and benign cysts, including serous cystadenomas (SCAs), are common pancreatic cystic lesions (PCLs) that are better managed conservatively. The burden of patients who undergo surgical resection for these cysts is unknown.
Samuel Tanner, Priyata Dutta, Elit Quingalahua, Jean M. Chalhoub, Fadi Hawa, Antonio Facciorusso, Gabriele Capurso, Un‐Jung Lee, Jorge D. Machicado   +8 more
wiley   +1 more source

Differences in Endoscopic Features of Gastric Neuroendocrine Tumor and Neuroendocrine Carcinoma From a Clinicopathological Perspective. [PDF]

JGH Open
Matsueda K, Uedo N, Kitamura M, Kawano S, Otsuka M.   +4 more
europepmc   +1 more source